<DOC>
	<DOCNO>NCT00057382</DOCNO>
	<brief_summary>This international , multicenter , randomize study intravenous T138067 versus intravenous doxorubicin hepatocellular carcinoma ( liver cancer ) . Patients treat chemotherapy surgery recommend cancer . A total 750 subject enrol study .</brief_summary>
	<brief_title>T138067 Versus Doxorubicin Chemotherapy-Naive , Unresectable , Hepatocellular Carcinoma Patients</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<criteria>Key inclusion criterion include : pathologic diagnosis unresectable HCC chemotherapynaïve HCC ChildPugh Class A B liver disease measurable disease ( i.e. , least one lesion least 20 mm one dimension ) computerize tomography ( CT ) scan magnetic resonance imaging ( MRI ) least one lesion least 10 mm spiral CT scan Karnofsky Performance Status ≥ 70 % life expectancy ≥ 12 week adequate hematologic function ( i.e. , absolute neutrophil count [ ANC ] ≥ 1500 cells/mm3 , platelet count ≥ 80,000 cells/mm3 , hemoglobin ≥ 8.5 g/dL ) total bilirubin ≤ 1.5 upper limit normal ( ULN ) aspartate transaminase ( AST ) alanine transaminase ( ALT ) ≤ 5 ULN serum creatinine ≤ 2 x ULN Key exclusion criterion include : severe , concurrent disease would make subject inappropriate enrollment Subjects receive prior intravenous intraarterial chemotherapy , chemoembolization , intratumoral ethanol injection , cryosurgery , radiofrequency ablation , embolization HCC . ( note : prior surgical resection , immunotherapy , hormonal therapy , radiotherapy , and/or orthotopic liver transplantation allow ) history cancer within past 5 year adequately treat basal cell squamous cell skin cancer , carcinoma situ cervix New York Heart Association ( NYHA ) class III IV heart disease leave ventricular ejection fraction &lt; 50 % acute anginal symptom female pregnant breastfeed receive investigational agent within 4 week enrollment history central nervous system metastases carcinomatous meningitis clinically apparent ascites major surgery within 4 week study enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2004</verification_date>
	<keyword>liver cancer</keyword>
</DOC>